TY - JOUR
T1 - Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection
AU - Anakwenze, Chidinma P.
AU - McGovern, Susan
AU - Taku, Nicolette
AU - Liao, Kaiping
AU - Boyce-Fappiano, David R.
AU - Kamiya-Matsuoka, Carlos
AU - Ghia, Amol
AU - Chung, Caroline
AU - Trifiletti, Daniel
AU - Ferguson, Sherise D.
AU - Li, Jing
AU - Yeboa, Debra Nana
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/9
Y1 - 2020/9
N2 - Background: The role of adjuvant radiation after gross total resection (GTR) for grade II meningioma is evolving, prompting further evaluation in NRG-BN003, a phase 3 national trial. Furthermore, the relationship between facility volume and outcomes in patients with grade II meningioma after GTR has not been examined at a national level. We aim to assess overall survival (OS) of patients with grade II meningioma after GTR by surgical case volume and OS by receipt of adjuvant radiation. Methods: We used the National Cancer Database to identity 2823 patients diagnosed with grade II meningioma who underwent GTR. Propensity score matching was applied to balance covariates in patients with grade II meningioma after GTR stratified by adjuvant radiation status. Multivariable logistic regression was used to assess factors associated with radiation receipt. Kaplan-Meier and log-rank tests were used to assess OS by facility volume. Results: As facility volume increased, OS increased, with a 5-year OS of 72.8% for facilities with GTR grade II meningioma volumes of ≤8 cases per decade and 87.5% for >8 cases per decade (P < 0.0001). There was no difference in 5-year OS between GTR alone and GTR with adjuvant radiation (84.8% vs. 86.4%; P = 0.151). Covariates significantly associated with radiation receipt included facility location, facility volume, distance, and tumor size. Conclusions: Treatment at higher surgical case volume facilities is associated with improved OS for GTR grade II meningioma. These facilities also have more patients receiving adjuvant radiation. However, we observed no difference in OS between adjuvant radiation and surgery alone.
AB - Background: The role of adjuvant radiation after gross total resection (GTR) for grade II meningioma is evolving, prompting further evaluation in NRG-BN003, a phase 3 national trial. Furthermore, the relationship between facility volume and outcomes in patients with grade II meningioma after GTR has not been examined at a national level. We aim to assess overall survival (OS) of patients with grade II meningioma after GTR by surgical case volume and OS by receipt of adjuvant radiation. Methods: We used the National Cancer Database to identity 2823 patients diagnosed with grade II meningioma who underwent GTR. Propensity score matching was applied to balance covariates in patients with grade II meningioma after GTR stratified by adjuvant radiation status. Multivariable logistic regression was used to assess factors associated with radiation receipt. Kaplan-Meier and log-rank tests were used to assess OS by facility volume. Results: As facility volume increased, OS increased, with a 5-year OS of 72.8% for facilities with GTR grade II meningioma volumes of ≤8 cases per decade and 87.5% for >8 cases per decade (P < 0.0001). There was no difference in 5-year OS between GTR alone and GTR with adjuvant radiation (84.8% vs. 86.4%; P = 0.151). Covariates significantly associated with radiation receipt included facility location, facility volume, distance, and tumor size. Conclusions: Treatment at higher surgical case volume facilities is associated with improved OS for GTR grade II meningioma. These facilities also have more patients receiving adjuvant radiation. However, we observed no difference in OS between adjuvant radiation and surgery alone.
KW - Adjuvant radiation
KW - Atypical meningioma
KW - Facility volume
KW - Grade II meningioma
KW - Gross total resection
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=85089734757&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089734757&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2020.05.030
DO - 10.1016/j.wneu.2020.05.030
M3 - Article
C2 - 32407910
AN - SCOPUS:85089734757
SN - 1878-8750
VL - 141
SP - e133-e144
JO - World neurosurgery
JF - World neurosurgery
ER -